Despite these challenges, it may be possible to model CRS in a xenograft model with intact recipient myeloid cells [186] and indeed, xenograft models have played an important role in helping to establish the role of GM-CSF in CAR T-cell toxicity [71], for example, despite their limitations. This evidence concerns the gene CSF2 and congenital rubella syndrome.